Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10363257 Bicyclic bromodomain inhibitors

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Peter Roland Young0

Bryan Cordell Duffy0

Gregory Scott Martin0

Gregory Steven Wagner0

John Frederick Quinn0

Shuang Liu0

Ruifang Wang0

May Xiaowu Jiang0

Date of Patent

July 30, 2019

0

Patent Application Number

158756780

Date Filed

January 19, 2018

0

Patent Citations

US Patent 10010556 Bicyclic bromodomain inhibitors

Patent Citations Received

US Patent 11884654 Substituted anilines as CCR(4) antagonists

0

US Patent 10793561 1,8-naphthyridinone compounds and uses thereof

US Patent 11584756 Heterocyclic compounds as BET inhibitors

US Patent 11028058 Heterocyclic compounds as adenosine antagonists

0

US Patent 11254670 1,8-naphthyridinone compounds and uses thereof

US Patent 11306071 Heterocyclic compounds as adenosine antagonists

US Patent 11446306 Bicyclic bromodomain inhibitors

Patent Primary Examiner

0

Patent abstract

The invention relates to substituted bicyclic compounds, which are useful for inhibition of BET protein function by binding to bromodomains, pharmaceutical compositions comprising these compounds, and use of the compounds and compositions in therapy.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10363257 Bicyclic bromodomain inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool